Suppr超能文献

[蛋白质合成抑制剂对维生素K诱导的血清中热稳定抗Xa因子含量变化的影响]

[Effect of protein synthesis inhibitors on the vicasol-induced change in the content of the thermostable antifactor Xa in the blood serum].

作者信息

Byshevskii A Sh, Galian S L

出版信息

Vopr Med Khim. 1980 Jan-Feb;26(1):85-8.

PMID:6768192
Abstract

Content of a thermostable inhibitor of thrombinogenesis (antifactor Xa) was decreased in blood serum after administration of pellentan. Subsequent treatment with vicasol normalized at the accelerated rate the antifactor Xa content in blood serum. Administration of the inhibitors of protein synthesis (vincrystine, actinomycin D, toyomycin, tetracycline--inhibitors of RNA polymerase, elongation, posttranscriptional conversions of mRNA and of translation processes, respectively (did not alter distinctly the vicasol effect--decrease in antifactor Xa content of blood serum. Vitamin K appears to participate in formation of the active molecule of the inhibitor of thrombinogenesis at the postribosomal step as shown in study of several other blood plasma procoagulants.

摘要

给予培冷坦后,血清中凝血酶生成的热稳定抑制剂(抗Xa因子)含量降低。随后用维生素K3治疗可加速血清中抗Xa因子含量恢复正常。给予蛋白质合成抑制剂(长春新碱、放线菌素D、丰加霉素、四环素,分别为RNA聚合酶、延伸、mRNA转录后转化和翻译过程的抑制剂)并未明显改变维生素K3的作用——血清中抗Xa因子含量降低。正如对其他几种血浆促凝血剂的研究所表明的,维生素K似乎在核糖体后步骤参与凝血酶生成抑制剂活性分子的形成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验